Time-dependent effects of training on cardiovascular control in spontaneously hypertensive rats: Role for Brain oxidative stress and inflammation and baroreflex sensitivity

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Masson, Gustavo S ^a   Costa, Tassia S R ^a   Yshii, Lidia ^a   Fernandes, Denise C ^a   Soares, Pedro Paulo Silva ^b   Laurindo, Francisco R ^a   Scavone, Cristoforo ^a   Michelini, Lisete C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; HEART RATE VARIABILITY; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; INFLAMMATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREADMILL EXERCISE; VAGUS REFLEX; VASOMOTOR REFLEX; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; HEART RATE; HEMODYNAMICS; MALE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART RATE; HEMODYNAMICS; HYPERTENSION; INFLAMMATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES;

EID: 84900450001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094927     Document Type: Article

References (39)

1. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ (2002). Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106: 945-949. (Pubitemid 34925328)
2. Cohuet G, Struijker-Boudier H (2006). Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther 111: 81-98. (Pubitemid 43765539)
3. Johansson M, Gao SA, Friberg P, Annerstedt M, Carlström J, et al. (2007). Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 25: 163-168. (Pubitemid 44885678)
4. Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, et al. (2008). EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 26: 1373-1378.
5. Montano N, Porta A, Cogliati C, Costantino G, Tobaldini E, et al. (2009). Heart rate variability explored in the frequency domain: A tool to investigate the link between heart and behavior. Neurosci Biobehav Rev 33: 71-80.
6. Zimmerman MC, Davisson RL (2004). Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 84: 125-149. (Pubitemid 38215209)
7. Touyz RM (2005). Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90: 449-455.
8. Rahmouni K, Davisson RL, Sigmund CD (2011). Inflaming hypothalamic neurons raises blood pressure. Cell Metab 14: 3-4.
9. Kang YM, Gao F, Li HH, Cardinale JP, Elks C, et al (2011). NF-κB in the paraventricular nucleus modulates neurotransmitters and contributes to sympathoexcitation in heart failure. Basic Res Cardiol 106: 1087-1097.
10. Cardinale JP, Sriramula S, Mariappan N, Agarwal D, Francis J (2012). Angiotensin II-induced hypertension is modulated by nuclear factor-κB in the paraventricular nucleus. Hypertension 59: 113-121.
11. Wei SG, Yu Y, Zhang ZH, Felder RB (2009). Angiotensin II upregulates AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296: H1425-H1433.
12. Shi Z, Gan XB, Fan ZD, Zhang F, Zhou YB, et al. (2011). Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats. Acta Physiol (Oxf) 203: 289-297.
13. Takagishi M, Waki H, Bhuiyan ME, Gouraud SS, Kohsaka A, et al. (2010). IL-6 microinjected in the nucleus tractus solitarii attenuates cardiac baroreceptor reflex function in rats. Am J Physiol Regul Integr Comp Physiol 298: R183-R190.
14. Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR, et al (2008). Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail 10: 625-634.
15. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, et al (2004). American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36: 533-553.
16. Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010). A molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Therap 128: 191-227.
17. Amaral SL, Michelini LC (2011). Effect of gender on training-induced vascular remodeling in SHR. Braz J Med Biol Res 44: 814-826.
18. Ceroni A, Chaar LJ, Bombein RL, Michelini LC (2009). Chronic absence of baroreceptor inputs prevents training-induced cardiovascular adjustments in normotensive and spontaneously hypertensive rats. Exp Physiol 94: 630-640.
19. Michelini LC, Stern JE (2009). Exercise-induced neuronal plasticity in central autonomic networks: role in cardiovascular control. Exp Physiol 94: 947-960.
20. Felix JV, Michelini LC (2007). Training-induced pressure fall in spontaneously hypertensive rats is associated with reduced angiotensinogen mRNA expression within the nucleus tractus solitarii. Hypertension 50: 780-785. (Pubitemid 47442745)
21. Agarwal D, Welsch MA, Keller JN, Francis J (2011). Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol 106: 1069-1085.
22. Pan YX, Gao L, Wang WZ, Zheng H, Liu D, et al (2007). Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension 49: 519-527.
23. Gao L, Wang W Liu D, Zucker IH (2007). Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115: 3095-3102. (Pubitemid 46957475)
24. Cavalleri MT, Burgi K, Cruz JC, Jordão MT, Ceroni A, et al. (2011). Afferent signaling drives oxytocinergic preautonomic neurons and mediates training-induced plasticity. Am J Physiol Regul Integr Comp Physiol 301: R958-R966.
25. Higa KT, Mori E, Viana FF, Morris M, Michelini LC (2002). Baroreflex control of heart rate by oxytocin in the solitary-vagal complex. Am J Physiol Regul Integr Comp Physiol 282: R537-R545. (Pubitemid 34664605)
26. Fernandes DC, Wosniak J, Pescatore LA, Bertoline MA, Liberman M, et al. (2007). Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am J Physiol Cell Physiol 292: C413-C422. (Pubitemid 46115149)
27. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, Lima L de S, et al. (2006). Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 26: 3813-3820.
28. Rong Y, Baudry M (1996). Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J Neurochem 67: 662-668. (Pubitemid 26255662)
29. Bristow JD, Gribbin B, Honour AJ, Pickering TG, Sleight P (1969). Diminished baroreflex sensitivity in high blood pressure and ageing man. J Physiol 202: 45P-46P.
30. Krieger EM, Da Silva GJ, Negrão CE (2001). Effects of exercise training on baroreflex control of the cardiovascular system. Ann N Y Acad Sci 940: 338-347. (Pubitemid 32623406)
31. Moraes-Silva IC, De La Fuente RN, Mostarda C, Rosa K, Flues K, et al (2010). Baroreflex deficit blunts exercise training-induced cardiovascular and autonomic adaptations in hypertensive rats. Clin Exp Pharmacol Physiol 37: 114-120.
32. Cruz JC, Cavalleri MT, Ceroni A, Michelini LC (2013). Peripheral chemoreceptors mediate training-induced plasticity in paraventricular nucleus pre-autonomic oxytocinergic neurons. Exp Physiol 98: 386-396.
33. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, et al (2009). Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22: 484-492.
34. Sriramula S, Cardinale JP, Francis J (2013). Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLOS One 15: e638-647.
35. Chan SH, Wang LL, Tseng HL, Chan JY (2007). Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens 25: 1845-1861. (Pubitemid 47356625)
36. Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB (2002). PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 90: 1012-1019. (Pubitemid 34633868)
37. Martins AS, Crescenzi A, Stern JE, Bordin S, Michelini LC (2005). Hypertension and exercise training differentially affect oxytocin and oxytocin receptor expression in the brain. Hypertension 46[part2]: 1004-1009.
38. Higa-Taniguchi KT, Felix JV, Michelini LC (2009). Brainstem oxytocinergic modulation of heart rate control in rats: effects of hypertension and exercise training. Exp Physio l 94: 1103-1113.
39. Szeto A, Nation DA, Mendez AJ, Dominguez-Bendala J, Brooks LG, et al (2008). Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 295: E1495-1501.